Resapp Health : Appendix 3B & Section 708A Notice

7 October 2016

ASX Announcements Office Exchange Centre

20 Bridge Street

SYDNEY NSW 2000

APPENDIX 3B & SECTION 708A NOTICE

An Appendix 3B for the issue of 2,437,500 Shares on conversion of Unlisted Options is attached. The Shares issued on conversion of the Options will remain escrowed until 14 July 2017.

The Company gives notice pursuant to Section 708A(5)(e) of the Corporations Act that the Shares issued were issued without disclosure under Part 6D.2, in reliance on Section 708A(5) of the Corporations Act. The Company, as at the date of this notice, has complied with the provisions of Chapter 2M of the Corporations Act as they apply to the Company and Section 674 of the Corporations Act. There is no excluded information to be disclosed for the purposes of Sections 708A(7) and (8) of the Corporations Act.

Yours faithfully

Nicki Farley Company Secretary

ResApp Health Limited ABN 51 094 468 318

Level 24, 44 St Georges Tce, Perth WA 6000

T [phone] E [e-mail] W www.resapphealth.com.au

Appendix 3B

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

RESAPP HEALTH LIMITED

ABN

51 094 468 318

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

Ordinary Fully Paid Shares

1 +Class of +securities issued or to be issued

2,437,500 Shares

1. Number of +securities issued or to be issued (if known) or maximum number which may be issued

   2,437,500 Shares (escrowed until 14 July 2017)

2. Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid

   +securities, the amount

   outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

   Shares - Yes

3. Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

   If the additional +securities do not rank equally, please state:

   • the date from which they do

   • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

   • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

     Shares issued on conversion of unlisted options at $0.026 per share.

4. Issue price or consideration

   Shares issued on exercise of unlisted options.

5. Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

Yes

6a Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

30 November 2015

6b The date the security holder resolution under rule 7.1A was passed

Nil

6c Number of +securities issued without security holder approval under rule 7.1

+ See chapter 19 for defined terms.

Appendix 3B Page 2 04/03/2013

Nil

6d Number of +securities issued with security holder approval under rule 7.1A

-

6e Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

2,437,500 Shares

6f Number of +securities issued under an exception in rule 7.2

Not applicable

6g If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the

+issue date and both values.

Include the source of the VWAP calculation.

Not applicable

6h If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

Listing Rule 7.1 - 12,475,273 Listing Rule 7.1A - 58,905,460

6i Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

7 October 2016

7 +Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

Number	+Class
592,945,853	Fully paid ordinary shares

8 Number and +class of all

+securities quoted on ASX (including the +securities in section 2 if applicable)